Allergy & Clinical Immunology News

Study Identifies CV Comorbidities Linked to Dermatomyositis The results "represent potential areas for preventative intervention," the researchers wrote.
Medscape Medical News, January 08, 2024
Alert FDA Gives Nod to Berdazimer Gel for Molluscum Contagiosum The topical treatment is expected to be commercially available in the second half of 2024.
Medscape Medical News, January 05, 2024
Expert Highlights Biologics in the Pipeline for Eczema Dr David Rosmarin reviewed several biologics in clinical trials that target interleukin-4 and other receptors.
MDedge News, January 05, 2024
US Dermatologic Drug Approvals Rose Between 2012 and 2022 Of the 52 new drugs approved in the past decade, 21% were categorized as first in class, but more innovations are needed for skin diseases with unmet therapeutic needs, the authors said.
Medscape Medical News, January 04, 2024
Assessing Patients With AD: Tools to Use in the Office "It can be overwhelming because there are many choices but so little time," says Dr Jonathan Silverberg, of George Washington University, Washington, DC.
MDedge News, January 04, 2024
Experimental Topical Drug Shows Promise for AD, Psoriasis In the phase 2 study, researchers at 34 sites in four countries randomized 104 patients with mild to moderate AD or psoriasis to receive the topical PDE4 inhibitor or a vehicle once daily for 6 weeks.
MDedge News, January 04, 2024
Long COVID Has Caused Thousands of US Deaths: New CDC Data Fresh estimates from the CDC show a growing death tally from long COVID —– with numbers expected to increase as diagnostic expertise improves.
Medscape Medical News, January 03, 2024
5-Year Safety Data From Upadacitinib Trials Reported Upadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick.
MDedge News, January 03, 2024
Conjunctivitis: How Common Is It in Patients on Dupilumab? Adults with AD have a significant and disease severity–dependent increased risk of developing ocular surface diseases, including conjunctivitis and keratitis.
MDedge News, December 29, 2023
Drugmakers Set to Raise US Prices on 500 Drugs in January Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed...
Reuters Health Information, December 29, 2023
Long COVID: New Info on Who Is Most Likely to Get It Fresh research and clinical anecdotes have given experts a much clearer picture of which patients are most likely to develop long COVID.
Medscape Medical News, December 27, 2023
Monoclonal Antibodies: A New Treatment for Long COVID? A small study generated impressive results.
Medscape Medical News, December 22, 2023
New Research Aims to Unravel Both ME/CFS and Long COVID A 2-day research conference sponsored by the US National Institutes of Health highlighted research that points to mechanisms that suggest potentially "druggable" pathways.
Medscape Medical News, December 21, 2023
US FDA Approves Sweden-based Calliditas' Kidney Disease Drug The U.S. Food and Drug Administration (FDA) granted full approval to Swedish drugmaker Calliditas Therapeutics' drug to treat rare kidney disease IgA Nephropathy (IgAN), the...
Reuters Health Information, December 20, 2023
Recent TB Infection Rare Among Immigrants to Canada Data suggest that few immigrants to Canada with tuberculosis infection were infected within the preceding 2 years, when the risk for progression to tuberculosis disease is the highest.
Medscape Medical News, December 19, 2023
Infections Down in Acute Care Hospitals Prevention strategies to reduce healthcare-associated infections are having an effect, according to a new report on national- and state-level incidence.
Medscape Medical News, December 18, 2023
Oral Immunotherapy Allays Peanut Allergy in Preschool Kids The peanut oral immunotherapy trial, POSEIDON, revealed promising outcomes in desensitizing preschool children with a peanut allergy, potentially reshaping early intervention strategies.
Medscape Medical News, December 18, 2023
Pilot Study Educates Barbers About Pseudofolliculitis Barbae In the study, barbers received questionnaires before and after an educational session on the recognition, cause, prevention, and treatment of PFB, which disproportionately affects Black men.
Medscape Medical News, December 18, 2023
Alert FDA Approves Tralokinumab for Treating Eczema in Adolescents It is the first treatment for pediatric patients with moderate-to-severe atopic dermatitis that specifically targets the interleukin (IL)-13 cytokine.
Medscape Medical News, December 15, 2023
Top 10 Fictional Docs on Streaming TV Both tried-and-true and out-of-the-ordinary holiday gift ideas are offered to those seeking a great present for a physician.
Medscape News Slideshows, December 15, 2023
Alert Antiparasitic Wins FDA Approval for High-Risk Neuroblastoma The FDA approved eflornithine to treat this rare cancer in adult and pediatric patients. The drug has also been approved to reduce excessive facial hair growth and to treat sleeping sickness.
Medscape Medical News, December 14, 2023
MSWS 2023 Misdiagnoses Among Challenges in Managing Cutaneous Lymphoma Although predictive tools to identify those at risk of disease progression are in their infancy, the development of such tools is crucial for improving patient outcomes.
Medscape Medical News, December 02, 2023
COVID Vaccines Lower Risk of Serious Illness in Kids Two doses of an mRNA COVID-19 vaccine reduced hospitalizations and emergency department visits by 40%.
Medscape Medical News, December 01, 2023
EADV 2023 Novel Subcutaneous Biologics Show Promise in AD Patients with moderate to severe atopic dermatitis could soon have more therapeutic options, with monoclonal antibodies targeting novel immune pathways that reduce disease severity, suggest two trials.
Medscape Medical News, December 01, 2023
Parental Stress and Depression Linked to Childhood Asthma Data from a national sample of Australian children showed worse asthma symptoms in the presence of family hardships, maternal depression, and other stressors.
Medscape Medical News, November 30, 2023
Tapinarof Effective for AD in Patients as Young as 2 years Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
MDedge News, November 28, 2023
Alert FDA Warns of Potentially Lethal Reaction to Seizure Meds Levetiracetam and clobazam can cause a rare but serious drug reaction with eosinophilia and systemic symptoms that can be life threatening if not diagnosed and treated quickly, the FDA warns.
Medscape Medical News, November 28, 2023
Global Measles Deaths Increased by 43% in 2022 The rise in measles outbreaks and deaths is not surprising, given the recent decline in vaccination rates, said an official of the US Centers for Disease Control and Prevention.
Medscape Medical News, November 28, 2023
Air in Remote First Nations Houses Tied to Respiratory Ills The air in First Nations houses in remote northwestern Ontario contains high concentrations of biocontaminants, mold, and fine particles that increase the risk of respiratory infections.
Medscape Medical News, November 27, 2023
Methotrexate Carries Higher Risk for Older CKD Patients Adverse event data showed an increased risk of myelosuppression, sepsis, pneumotoxic effects, or hepatotoxic effects.
Medscape Medical News, November 27, 2023
Parent Concerns a Factor When Treating Patients With AD For a parent whose child has an inflammatory skin disease, pigmentation changes, rather than inflammation, might be the reason that he or she brought the child to the clinician.
MDedge News, November 23, 2023
How Has the COVID-19 Pandemic Affected Sleep Quality? Researchers presented data about the relationship between sleep and outcomes such as response to vaccination and recovery from COVID-19.
Medscape Medical News, November 22, 2023
Risks Quantified in Medically Optimized Pregnancy With Lupus Patients who were not medically optimized for pregnancy were three times more likely to experience preterm birth and preeclampsia.
Medscape Medical News, November 21, 2023
AHA 2023 Alternative Antirejection Regimen in Pediatric Heart Transplant Results of the head-to-head TEAMMATE trial show the combination of everolimus and low-dose tacrolimus can be considered an alternative to MMF plus tacrolimus in pediatric heart transplant.
MDedge News, November 21, 2023
Why Intense Exercise May Lead to a Cold Inactivity has emerged as a risk factor for respiratory infections but too much physical activity could also increase susceptibility.
Medscape Medical News, November 21, 2023
ACR 2023 Novel Blood Test Can Detect Rheumatoid Arthritis An experimental assay detects epigenetic features within the unique patterns and sizes of cell-free DNA found in blood, but is it better than clinical diagnostics?
MDedge News, November 20, 2023
Lebrikizumab Gets the Nod in the EU for Atopic Dermatitis Lebrikizumab, an interleukin-13 inhibitor, is not yet approved in the United States.
MDedge News, November 20, 2023
Use the Stool! Fecal Transplants Help Kids With C Diff The American Academy of Pediatrics endorsed fecal transplants to eliminate a particular infection in children and called for more research about other uses.
Medscape Medical News, November 20, 2023
Before Signing an Offer Letter: Read This You just received an offer letter, but should you sign it right away? How legally binding is it? Is it the same as a contract? Experts weigh in.
Medscape Medical News, November 17, 2023
New Consensus Guide on Rare Drug Hypersensitivity Reaction Experts provided parameters to help clinicians, but they acknowledged the limited evidence base for drug reaction with eosinophilia and systemic symptoms.
Medscape Medical News, November 17, 2023

No Results